Yüklüyor......
Pioglitazone in Clinical Practice: Where Are We Now?
Pioglitazone, a thiazolidinedione, improves insulin sensitivity and thus reduces blood glucose. Clinical trials have suggested potential cardiovascular outcome benefits in association with pioglitazone; however, safety concerns are mounting, with recent data suggesting a link between pioglitazone an...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Springer Healthcare Communications
2012
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3508118/ https://ncbi.nlm.nih.gov/pubmed/22373598 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-012-0001-z |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|